Stock 9996 PEIJIA MEDICAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Peijia Medical Limited

Equities

9996

KYG6981F1090

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:03 2024-03-28 EDT 		5-day change 1st Jan Change
3.66 HKD -3.94% Intraday chart for Peijia Medical Limited -.--% -50.47%
04-08 JenaValve Technology, Inc. announced that it has received $100.4 million in funding from a group of investors CI
04-02 Peijia Medical Limited Delays in Publication of 2023 Annual Results CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
PEIJIA MEDICAL LIMITED Stock Peijia Medical Limited
-50.47% 316M -
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-7.58% 10.74B
A-
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+2.17% 8.93B
C
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
+22.75% 7.61B
C
GLAUKOS CORPORATION Stock Glaukos Corporation
+33.99% 5.27B
B+
AXONICS, INC. Stock Axonics, Inc.
+8.12% 3.42B
C-
ENOVIS CORPORATION Stock Enovis Corporation
-8.48% 2.86B
B-
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-5.07% 2.23B - -
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-4.22% 2.13B -
DOUBLE MEDICAL TECHNOLOGY INC. Stock Double Medical Technology Inc.
-20.87% 1.84B -
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. 9996 Stock
  4. Ratings Peijia Medical Limited